MayoClinicRadio podcast: 11/30/19
Listen: Mayo Clinic Radio 11/30/19 On an encore presentation of the Mayo Clinic Radio podcast, Dr. William Young Jr., a Mayo Clinic endocrinologist, discusses pituitary gland tumors. Also on the podcast, Dr. Emanuel Trabuco, chair of Mayo Clinic's Division of Urogynecology, explains treatment options for stress urinary incontinence in women. And Dr. Joy Wolfram, a Mayo Clinic researcher, shares how nanomedicine seeks to [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 1, 2019 Category: Databases & Libraries Source Type: news
Quebec's college of physicians to investigate surgeries that remove incontinence sling
An investigation by Radio-Canada's Enquête found over 30 women, implanted with suburethral slings, felt the need to have the devices surgically removed in the United States because they no longer trust that urologists in Quebec can perform the surgery properly. (Source: CBC | Health)
Source: CBC | Health - November 29, 2019 Category: Consumer Health News Tags: News/Canada/Montreal Source Type: news
Renovia Receives FDA OK for Next Generation Pelvic Digital Therapeutic
Renovia has received a nod from FDA for a next-generation pelvic digital therapeutic. The Boston-based company said the Ieva device is cleared for the strengthening of pelvic floor muscles and the treatment of stress, mixed, and mild to moderate urgency urinary incontinence (UI) in women.
The next-generation leva Digital Therapeutic uses Renovia’s movement-based sensor and app technology to provide women real-time feedback as they perform their pelvic floor muscle exercises. The new leva Digital Therapeutic is based on the same mechanism of action and sensor technology found in current-generation leva Dig...
Source: MDDI - November 25, 2019 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Source Type: news
Medtech in a Minute: Hologic & #039;s Cynosure Flop, Axonics Stands Its Ground, and More
Axonics Not Intimidated by Medtronic
Axonics' implantable rechargeable sacral neuromodulation device is now FDA-approved for the treatment of fecal incontinence, overactive bladder, and urinary retention. Medtronic is suing Axonics for alleged patent infringement, but the company does not appear to be intimidated.
Â
Thermo Fisher May Fancy Qiagen
The rumor mill was lit with a recent Bloomberg report of a potential $8 billion Thermo Fisher-Qiagen deal. Qiagen acknowledged that it has received several "indications of interest" but the company...
Source: MDDI - November 22, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
Management of Urinary Incontinence in Midlife Women Management of Urinary Incontinence in Midlife Women
Urinary incontinence in mid-life women is common, stigmatizing, and treatable. Review its diagnosis and management options in this Practice Pearl.Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 21, 2019 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news
Revision, Removal Risks Low for Synthetic Midurethral Slings
MONDAY, Nov. 18, 2019 -- The long-term risk for women with stress urinary incontinence needing surgical revision or removal after initial placement of synthetic midurethral slings is low, according to a study published in the November issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2019 Category: Pharmaceuticals Source Type: news
Axonics Isn & #039;t Letting Medtronic Stand in Its Way
For 22 years, the world's largest pure-play medical device company was the only player in sacral neuromodulation, a space that addresses urinary problems as well as fecal incontinence. Now there's a new kid on the block, which has created quite an intense David vs. Goliath medtech story.
For those unfamiliar with the Axonics vs. Medtronic story up to this point, click here for a quick rundown of recent events that have transpired in this market.
Â
FDA Approves Second Indication for Axonics r-SNM
FDA approved the urinary indications for an implantable rechargeable sacral neuro...
Source: MDDI - November 18, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Implants Source Type: news
Urinary Incontinence & OAB | Medscape Urinary Incontinence & OAB | Medscape
Review in-depth clinical information, latest medical news, and guidelines on urinary incontinence, urge incontinence, and adult incontinence. Read about overactive bladder (OAB) and overactive bladder treatment. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 12, 2019 Category: Consumer Health News Tags: Resource Center Source Type: news
Medtronic Sues Axonics for Patent Infringement
The medical device industry has seen its share of David vs. Goliath stories over the years, but few have been as intense as the battle between Medtronic and Axonics over the sacral neuromodulation (SNM) market. The story took an unexpected turn this week as Medtronic slapped Axonics with a patent infringement lawsuit that is likely to take years to play out.
Medtronic (the Goliath of this story), filed a lawsuit against Axonics Modulation Technologies (the David of the story), alleging infringement of four patents related to Medtronic's SNM lead placement procedure and implant recharging technologie...
Source: MDDI - November 5, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Implants Source Type: news
Reoperation Unlikely After Midurethral-Sling Surgery Using Synthetic Mesh Reoperation Unlikely After Midurethral-Sling Surgery Using Synthetic Mesh
Up to nine years after midurethral-sling surgery with synthetic mesh for stress urinary incontinence, only a small minority of women will require reoperation, according to a large retrospective study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - October 22, 2019 Category: Surgery Tags: Urology News Source Type: news
Johnson & Johnson settlement on surgical mesh includes $2.8M for Arizona
Arizona will receive $2.8 million of a nearly $117 million settlement that Johnson& Johnson has reached over safety concerns and misleading marketing of a surgical mesh used to treat urinary incontinence and other pelvic floor disorders, Arizona Attorney General Mark Brnovich said.
The nationwide settlement involved transvaginal surgical meshes implanted to treat a variety of pelvic floor issues. But state prosecutors in 41 states and the District of Columbia said it caused pain, incontinence,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 21, 2019 Category: Biotechnology Authors: Emily Mae Dean Source Type: news
Johnson & Johnson settlement on surgical mesh includes $2.8M for Arizona
Arizona will receive $2.8 million of a nearly $117 million settlement that Johnson& Johnson has reached over safety concerns and misleading marketing of a surgical mesh used to treat urinary incontinence and other pelvic floor disorders, Arizona Attorney General Mark Brnovich said.
The nationwide settlement involved transvaginal surgical meshes implanted to treat a variety of pelvic floor issues. But state prosecutors in 41 states and the District of Columbia said it caused pain, incontinence,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 21, 2019 Category: Pharmaceuticals Authors: Emily Mae Dean Source Type: news
#MayoClinicRadio podcast: 10/12/19
Listen: Mayo Clinic Radio: 10/12/19 On the Mayo Clinic Radio podcast, Dr. Jean Fox, a Mayo Clinic gastroenterologist, discusses fecal incontinence, including treatment options and prevention. Also on the podcast, Dr. Ekta Kapoor, a Mayo Clinic internal medicine and women's health physician, explains the dangers of excess belly fat. And Dr. Michael Joyner, a Mayo Clinic anesthesiologist and human performance [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 13, 2019 Category: Databases & Libraries Source Type: news
Medtech in a Minute: A Supreme Court Rejection, a Brewing Market Battle, and New Data
Zimmer Biomet Is Stuck with Hefty Infringement Award
The U.S. Supreme Court struck down Zimmer Biomet's request for the high court to review the scope of the damages awarded in a patent infringement case against Stryker. The $248M judgment was one of the largest ever awarded for enhanced patent damages and could have broad ramifications for the entire industry.
Â
Medtronic Is Hot on Axonics' Heels in SNM
Medtronic filed for FDA approval of its InterStim Micro sacral neuromodulation (SNM) device for bladder-related issues and fecal incontine...
Source: MDDI - October 11, 2019 Category: Medical Devices Tags: Business Source Type: news
Medtronic and Axonics Go Toe-to-Toe in Fast-Growing Sacral Neuromodulation Market
Medtronic and Axonics are getting ready to square off in sacral neuromodulation, a fast-growing market that was monopolized by Medtronic until a month ago.
Last month, Axonics won FDA approval to market its implantable rechargeable sacral neuromodulation (r-SNM) device for the treatment of fecal incontinence, and the company is expected to get FDA approval for overactive bladder and urinary retention any time now. The fecal incontinence approval includes the claim of a 15-year functional life and the ability of patients to undergo full-body MRI scans without the necessity of having the device explanted.
Medtron...
Source: MDDI - October 8, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
